Document is current
Any future updates will be listed below
-
Authors
Chen, Yingtai http://orcid.org/0000-0002-4342-4335
Yin, Jianhua
Zhao, Lulu
Zhou, Guangyu
Dong, Shichen
Zhang, Yueming
Niu, Penghui
Ren, Hu
Zheng, Tianjiao
Yan, Juan
Li, Wenbin
Ma, Peiqin
Zhang, Cuijuan
Wei, Chen
Church, George
Li, Guibo
Zhao, Dongbing
-
Funding
Funding for this research was provided by:
the National Key R&D Program of China (2017YFC0908300)
Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20170412153155228)
Shenzhen Key Laboratory of Single-Cell Omics (ZDSYS20190902093613831)
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 24 November 2022
First Online: 6 December 2022
Declarations
:
: All clinical samples were collected from the Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Written informed consent was obtained from all participants enrolled in this study, and ethical approval was obtained from the following institutional review boards in accordance with the Declaration of Helsinki: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Approval number: 17-156/1412. Issued date: 2017-09-14.
: The authors declare no conflict of interest.
